orphenadrine and pk 11195

orphenadrine has been researched along with pk 11195 in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Camarasa, J; Camins, A; Canudas, AM; Escubedo, E; Pallàs, M; Pubill, D; Sureda, FX; Verdaguer, E1

Other Studies

1 other study(ies) available for orphenadrine and pk 11195

ArticleYear
Orphenadrine prevents 3-nitropropionic acid-induced neurotoxicity in vitro and in vivo.
    British journal of pharmacology, 2001, Volume: 132, Issue:3

    Topics: Animals; Antihypertensive Agents; Blotting, Western; Body Weight; Cell Survival; Cerebellum; Corpus Striatum; Disease Models, Animal; Drug Interactions; Isoquinolines; Male; Mortality; Muscarinic Antagonists; Neurotoxicity Syndromes; Nitro Compounds; Orphenadrine; Propionates; Radioligand Assay; Rats; Rats, Sprague-Dawley; Tritium

2001